The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1250 articles
When individuals search for 'weight loss,' Ozempic often appears prominently despite lacking FDA approval for that purpose. This occurs through paid search advertisements that bypass traditional ad regulations. Experts urge consumers to seek independent sources for accurate health information.
An Instagram video by a personal trainer offering advice on how to get 'skinny' legs has drawn criticism. The video, which gained nearly 400,000 views, sparked debate within the fitness community, with some experts warning against the potentially harmful messaging.
A recent article highlights key considerations for individuals seeking qualified medical weight loss providers, particularly concerning GLP-1 treatments. It stresses the importance of thorough evaluations, ongoing monitoring, and comprehensive plans for effective and sustainable weight management.
Discover the leading semaglutide choices for weight loss in 2026. This article examines FDA-approved GLP-1 programs, safety protocols, access methods, and the structure of MEDVi's online weight loss platform. As medical weight loss evolves, understanding the best options is crucial.
This article explores the use of Ozempic for weight loss, examining its effectiveness and safety. It also provides information on PhenQ as an alternative weight loss supplement.
Investing in Novo Nordisk (NVO), the maker of Ozempic and Wegovy, has faced challenges recently, with shares declining. However, recent FDA approval of an oral form of Wegovy could change the company's trajectory. Analyzing competition and market dynamics is vital for investment decisions.
As weight loss becomes a popular New Year's resolution, many are turning to GLP-1 medications. However, scammers are leveraging fake websites and offers to steal money and personal data. The Better Business Bureau warns of fraudulent schemes targeting those seeking weight loss solutions.
DrMedHealth.com is now offering its GLP-1 medical weight loss programs across the nation, giving adults in the United States and Washington, DC, access to licensed doctors and prescription-based weight management services. The platform facilitates a comprehensive telehealth experience, enabling patients to undergo online health evaluations, receive assessments from licensed healthcare professionals, and, if deemed appropriate, commence treatment remotely.
A recent study published in the Journal of Marketing Research indicates that families using GLP-1 medications are reducing their spending on food. The research examined purchasing habits and revealed a correlation between GLP-1 use and decreased spending on groceries and dining out.
